Masamitsu Yanada, Satoshi Yamasaki, Hiroki Hosoi, Shohei Mizuno, Kaito Harada, Noriko Doki, Shin-Ichiro Fujiwara, Nobuhiro Hiramoto, Yuta Hasegawa, Kazuya Ishiwata, et al. Association of FLT3-ITD and NPM1 mutations with outcomes of allogeneic hematopoietic cell transplantation in acute myeloid leukemia. Bone marrow transplantation. 2025
Satoshi Yamasaki, Masamitsu Yanada, Hiroaki Araie, Takahiro Fukuda, Yoshinobu Kanda, Haruko Tashiro, Naoyuki Uchida, Kazutaka Ozeki, Shuichi Ota, Yasushi Onishi, et al. Comparative analysis of allogeneic hematopoietic cell transplantation in patients with therapy-related and de novo acute promyelocytic leukemia A retrospective study. Scientific reports. 2025. 15. 1. 10967-10967
Takaaki Konuma, Megumi Hamatani-Asakura, Maki Monna-Oiwa, Seiko Kato, Masamichi Isobe, Kazuaki Yokoyama, Yasuhito Nannya, Satoshi Takahashi. Higher relapse and worse overall survival in recipients with CTLA-4 AA genotype of rs231775 following single-unit cord blood transplantation in adults. Leukemia & Lymphoma. 2025. 66. 4. 733-743
Takaaki Konuma, Machiko Fujioka, Kyoko Fuse, Hiroki Hosoi, Yosuke Masamoto, Noriko Doki, Naoyuki Uchida, Masatsugu Tanaka, Masashi Sawa, Tetsuya Nishida, et al. Clinical effects of granulocyte colony-stimulating factor administration and the timing of its initiation on allogeneic hematopoietic cell transplantation outcomes for myelodysplastic syndrome. Transplantation and Cellular Therapy. 2025
Satoshi Mitsuyuki, Yoshimitsu Shimomura, Hiroki Mizumaki, Masamitsu Yanada, Shohei Mizuno, Tetsuya Nishida, Makoto Onizuka, Md Tanaka, Koji Kawamura, Masatsugu Tanaka, et al. Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia with t(16;21)(p11;q22). BLOOD. 2024. 144. 1469-1470
小沼貴晶. PTCy for GVHD prophylaxis based on BMT CTN 1703 trial. 月刊血液内科. 2024. 88. 5. 521-527
Eita Miyashita, Nozomi Sugihara, Miho Tanaka, Hiromi Iwasaki, Maki Monna-Oiwa, Masamichi Isobe, Seiko Kato, Satoshi Takahashi, Yasuhito Nannya, Yukari Tsuru, et al. Prevalence and factors of polypharmacy among disease-free survivors of adults after allogeneic hematopoietic cell transplantation. LEUKEMIA & LYMPHOMA. 2024. 65. 4. 516-520
加藤せい子, 濱谷恵, 大岩真希, 磯部優理, 横山和明, 南谷泰仁, 高橋聡, 小沼貴晶. Donor NKG2D polymorphism predicts hematopoietic engraftment, severe acute GVHD, and NRM after CBT. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2024. 46th
今橋伸彦, 栗田尚樹, 小沼貴晶, 高橋聡, 西田徹也, 田中正嗣, 中前博久, 河北敏郎, 太田秀一, 土岐典子, et al. Effect of conditioning regimens and GVHD prophylaxis on UCBT performed with CY/TBI-based regimens. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2024. 46th
Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia with t(16;21)(p11;q22)
(BLOOD 2024)
Installment of Automation and Modernized Culture Methods Updates a Drug-Sensitivity Screening Platform and Paves the Way to Next-Generation of Precision Medicine
(BLOOD 2024)
The Asia Pacific Blood and Marrow Transplantation group
, The American Society for Transplantation and Cellular Therapy
, 日本輸血・細胞治療学会
, 日本感染症学会
, 日本造血細胞移植学会
, THE JAPANESE SOCIETY OF HEMATOLOGY
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE